The present investigation included 71 patients who underwent surgery during a 6-year period at our in stitution. The objective of this retrospective study was to investigate: 1) the current appropriate indica tions for surgery in cerebral cavernous angioma; 2) which patients definitely benefit from the surgical removal of a cavernous malformation;
3) which pa tients harboring a cerebral cavernous angioma must be considered at high risk for postoperative morbidi ty; 4) if surgery is clinically indicated, the optimal timing for the procedure in patients not presenting with massive hemorrhage.
Special emphasis is placed on these questions because neurosurgeons are now dealing more frequently with cavernomas than in the past; and the incidence of hemorrhage and overall morbidity in the natural history of cavernous malformations are not entirely understood. 27,38) Only recently have studies provided preliminary in formation about the risk of hemorrhage in patients
Clinical

Materials
and Methods Seventy-one  consecutive  patients  underwent  microsurgical removal of symptomatic and histo logically confirmed cerebral cavernous angiomas be tween August, 1983 and December, 1989 at the De partment of General Neurosurgery, University of Freiburg. Two individuals harbored two caverno mas each at different locations which were treated surgically at different times. There were 38 males (54%) and 33 females (46%), ranging in age from 5 to 63 years (mean, 37 yrs). Familial occurrence was seen in two patients who were siblings.
I. Patient population
II. Clinical presentation
Epileptic seizures were the only preoperative com plaints in 29 patients. Another 16 combined seizures with various neurological deficits. Among the pa tients presenting with seizures, 21 suffered from generalized convulsions, seven from each of focal and complex partial seizures, and 10 from combined seizures. The incidence was low (one or up to three episodes of seizures in history) in 17 in dividuals, moderate (four seizures in history or several per year) in 13, and high (several seizures per month or more) in 15. Twenty-six patients received anticonvulsants, but the incidence of seizure was satisfactorily reduced in only 11 patients. The age, sex, and location, side, or size of the malformation did not significantly influence the incidence or the pattern of epileptic seizures.
Forty-nine patients presented with the clinical pic ture of a cerebral space-occupying lesion ( Fig. 1 ). Progressive focal neurological deficits were manifest preoperatively in 44 individuals. The neurological disorders included impairment of cranial nerve func tion in 25 patients, sensory disturbances (chiefly hemihypesthesia and paresthesia) in 19, and motor deficits (predominantly hemiparesis) in 15. Severe headache, disorientation, dysphasia, dysarthria, trigeminal neuralgia, nystagmus, ataxia, and vertigo were additional signs and symptoms frequently en countered in these patients, depending upon the loca tion of the malformation.
Two patients with supratentorial cavernomas and three with lesions located in the quadrigeminal plate of the midbrain had symptoms of increased intracranial pressure. In the latter cases, this was due to obstructive hydrocephalus ( Fig. 2) , each requiring placement of a ventriculoatrial shunt prior to the removal of the vascular malformation. Cavernomas 2 cm in diameter or greater caused neurological deficits significantly more frequently than those less than 2 cm in diameter. year follow-up, he was symptom-free. Table 1 CT  findings  of  73 cerebral  cavernous   angiomas   Table 2 Location of 73 cavernous angiomas III. History The period between first onset of complaints and surgery varied widely, ranging between 2 weeks and 26 years (mean, 49 mos). Seizures were of long standing duration in most patients (mean, 65 mos). With one exception, patients harboring a pontine cavernoma had the shortest symptom duration (mean, 2.5 mos). Symptoms became manifest at a mean age of 33 years. Forty-four patients suffered a sudden onset of complaints.
In the others, the symptoms developed gradually and most commonly progressed.
IV. Neuroradiological
findings Table 1 lists the various findings from preoperative computed tomographic (CT) scans in each patient. There were seven midline lesions (located in the cerebellar vermis, pons, or quadrigeminal plate of the midbrain), and 34 involving the right and 32 the left hemisphere. Table 2 displays the distribution of malformations according to location. Obviously, 47 lesions (64%) were quite easily accessible, whereas 26 (36%) were located deeply, in functionally important regions of the brain. The greatest CT diameter of the lesions ranged from 0.5 to 4 cm (mean, 1.9 cm).
Preoperative MR imaging in 60 patients was partic ularly useful in confirming the suspected diagnosis of cavernous angioma and in delineating the relation ship of the malformation to the surrounding brain structures (Figs. 4 and 5).
Cerebral angiography was performed in each case. A normal angiogram was found in 50 cases. A subtle but definite vascular stain was evident in only two pontine cavernomas. Filling of prominent draining veins adjacent to the cavernoma was seen in four frontal, and one each of temporal, occipital, insular, and pontine malformations, suggesting a venous angioma. Table 3 . Table 4 summarizes the overall surgical outcome by discharge (10-14 days after surgery in 61 cases). Of the patients not presenting with neurological dis orders, only one experienced transient deficits fol lowing the procedure which had resolved by follow up examination.
The surgical complications are listed in Table 5 . A detailed analysis of the com plications encountered in patients with deep-seated malformations has been presented elsewhere.')
II. Follow-up
Follow-up data were available from 65 individuals (92%), obtained from questionnaires, telephone con tact, or re-examination.
The mean follow-up period was 15 months, ranging from 8 months to 5 years.
The evolution of the seizure disorder by follow-up examination is presented in Table 6 . Excluding the first 5 postoperative days, 27 patients presenting with epileptic seizures remained seizure-free, either with or without antiepileptic medication. The prevalence of seizures clearly decreased from 60% preoperative ly to 18% postoperatively.
Additionally, the in cidence was markedly reduced in 75% of the 12 patients still suffering from convulsions. These 12 individuals had a significantly longer duration of symptoms (mean, 124 mos) compared with the seizure-free patients (mean, 34 mos). The size of the lesion did not influence the outcome. Table 7 summarizes the evolution of the main neurological disorders. In 15 of the 22 patients with unsatisfactory neurological condition in the early postoperative stage, deficits had resolved or marked ly improved by follow-up examination.
Overall, by follow-up examination, 35 individuals (54%) were symptom-free, 16 (25%) had improved preoperative complaints, six (9%) remained un changed, and eight (12%) had deteriorated. continues over whether sur gical or conservative treatment is preferable in such cases. 3,4,9,19,21,28,32,37,42) Previously, surgical removal of deep-seated lesions, particularly of those located within the brainstem, has been carried out mainly in patients with local massive bleeding'," 1,13,21,36,41) or with recurrent subarachnoid hemorrhage.31) We also consider that extirpation of the malformation is the therapy of choice in such cases, in order to avoid a second, potentially fatal bleeding.
Apart from cases with major bleeding, we oper ated on patients with cavernomas in sensitive regions of the brain presenting with various symp toms other than massive hemorrhage from the mal formation. Only a few similar cases have been pub lished. 26,40,42) In the initial period, our results were sometimes disappointing. Later, our surgical success rate has clearly increased, and serious complications have become a rarity since 1988.') Encouraged by these results, and like several authors, 5,10,26,42) we now prefer a rather aggressive surgical policy in patients presenting with either repetitive minor bleeding (and correlating symptoms) or with sustained neurological deficits, provided that the malforma tion extends close to or reaches the surface of the brainstem or ventricles, including the surface of the third ventricle. We must be aware, however, that these individuals face the highest risk for transient and even permanent morbidity attributable to the surgical intervention.
A single episode of minor bleeding, or less severe symptoms which rapidly resolved, is not necessarily a surgical indication upon deep-seated lesions.
In contrast to arteriovenous malformations whose natural history is now well defined,","' the yearly risk for massive hemorrhage from cavernoma is dif ficult or impossible to precisely predict. Del Curling et al." recently estimated the annualized bleeding rate at 0.25%/person-year of exposure, and Robinson et al.") 0.7%. The risk of rebleeding after an initial hemorrhage, however, remains un known.') Nevertheless, there is no doubt that these lesions can be the source of major hemorrhage, and the consequence of such an episode in a patient harboring a deep-seated cavernoma may be devas tating. 6,22,27,42) A careful evaluation of the optimal therapy is therefore mandatory in patients with a symptomatic deep-seated cavernoma not presenting with massive bleeding. There is no indication for surgery in patients with clinically silent cavernous angiomas located in critical regions of the brain, particularly when approaching these lesions would require traversing healthy and functionally impor tant cerebral structures.
Certainly, such patients need to be carefully followed clinically and neuro radiologically at least once per year.
